Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes

Clinical and Experimental Immunology

Volumn 154, Issue 3, 2008, Pages 360-364

  Santini, D ^a   Angeletti, S ^a   Ruzzo, A ^b   Dicuonzo, G ^a   Galluzzo, S ^a   Vincenzi, B ^a   Calvieri, A ^a   Pizzagalli, F ^b   Graziano, N ^a   Ferraro, E ^a   Lorino, G ^c   Altomare, A ^a   Magnani, M ^b   Graziano, F ^d   Tonini, G ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b UNIVERSITY OF URBINO   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Hospital of Urbino   (Italy)

Author keywords

Gastric cancer; Incidence; Polymorphisms; TLR 4

Indexed keywords

ASPARTIC ACID; GLYCINE; ISOLEUCINE; THREONINE; TOLL LIKE RECEPTOR 4;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR GENE; RISK FACTOR; STOMACH CANCER; TLR4 GENE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; STOMACH NEOPLASMS; TOLL-LIKE RECEPTOR 4;

EID: 55449103507     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03776.x     Document Type: Article

References (29)

1. Armant MA, Fenton M. Toll-like receptors: a family of pattern recognition receptors in mammals. Genome Biol 2002 3 : 3011 16.
2. Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of Toll-like receptor mediated immune response. Nat Rev Immunol 2005 5 : 446 58.
3. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004 4 : 499 511.
4. Akira S, Sato S. Toll-like receptors and their signalling mechanism. Scand J Infect Dis 2003 35 : 555 62.
5. Pesare C, Medzhitov R. Toll-dependent control mechanisms of CD4 T cell activation. Immunity 2005 22 : 397 9.
6. Cook DN, Pisetski DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004 5 : 975 79.
7. Opal SM, Esmon CT. Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 2003 7 : 23 38.
8. Arbour NC, Lorenz E, Schutte BC et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000 25 : 187 9.
9. Mockenhaupt FP, Cramer JP, Hamann L et al. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. J Commun Dis 2006 38 : 230 45.
10. Achyut BR, Ghoshal UC, Moorchung N, Mittal B. Association of Toll-like receptor-4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesions. Hum Immunol 2007 68 : 901 7.
11. Lawrence T. Inflammation and cancer: a failure of resolution? Trends Pharmacol Sci 2007 28 : 162 5.
12. Garza-Gonzalez E, Bosques-Padilla FJ, Mendoza-Ibarra SI, Flores-Gutierrez JP, Maldonado-Garza HJ, Perez-Perez GI. Assessment of the Toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8-251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer 2007 7 : 70.
13. El-Omar EM, Ng MT, Hold GL. Polymorphisms in Toll-like receptor genes and risk of cancer Review Oncogene 2008 27 : 244 52.
14. Sun J, Wiklund F, Zheng SL et al. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J Natl Cancer Inst 2005 97 : 525 32.
15. Cheng I, Plummer SJ, Casey G, Witte JS. Toll-like receptor 4 genetic variation and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007 16 : 352 55.
16. Lochhead P, El-Omar EM. Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol 2007 21 : 281 97.
17. Schmausser B, Andraulis M, Endrich S et al. Expression and subcellular distribution of Toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 2004 136 : 521 6.
18. Smith MF, Mitchell A, Li G et al. TLR2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kB activation and chemokine expression by epithelial cells. J Biol Chem 2003 278 : 33552 60.
19. Kato I, Canzian F, Plummer M et al. Polymorphisms in genes related to bacterial lipopolysaccharide/peptidoglycan signalling and gastric precancerous lesions in a population at high risk for gastric cancer. Dig Dis Sci 2007 52 : 254 61.
20. Hamajima N. Persistent Helicobacter pylori infection and genetic polymorphisms of the host. Nagoya J Med Sci 2003 66 : 103 8.
21. Rallhabendi P, Bell J, Boukhvalova MS et al. Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure and signaling. J Immunol 2006 177 : 322 32.
22. Van der Graaf C, Kullberg BJ, Joosten L, Verver-Jansen Jacobs L, van der Meer JW, Netea MG. Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism. Cytokine 2005 30 : 264 68.
23. Erridge C, Stewart J. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like recptor 4 gene show no deficit in lipopolysaccharide signalling. J Exp Med 2003 197 : 1787 91.
24. Hold GL, Rabkin CS, Chow WH et al. A functional polymorphism of Toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 2007 132 : 905 12.
25. El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000 404 : 398 402.
26. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988 16 : 1215.
27. Lorenz E, Frees KL, Schwartz DA. Determination of TLR4 genotype using allele-specific PCR. Biotechniques 2001 31 : 22 4.
28. Strober W, Murray PJ, Kitani A, Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 2006 6 : 9 20.
29. Abraham C, Cho JH. Functional consequences of NOD2 (CARD15) mutations. Inflamm Bowel Dis 2006 12 : 641 50.